Archive for the ‘Respiratory / Asthma’ Category
Monday, March 3rd, 2008
Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, today announced that it has achieved human proof of concept with an RNAi therapeutic, a first for the industry. Results from the company's GEMINI trial with ALN-RSV01, an RNAi therapeutic for the treatment of respiratory syncytial virus (RSV), showed statistically ...
Posted in Respiratory / Asthma | No Comments »
Thursday, February 28th, 2008
Researchers at Mayo Clinic and the Virginia Bioinformatics Institute (VBI) have received a second grant from the National Institute of Allergy and Infectious Diseases (NIAID) to advance understanding of the role of environmental fungi in chronic airway disorders. Recently NIAID awarded the researchers a further $1.8 million for these studies ...
Posted in Respiratory / Asthma | No Comments »
Tuesday, February 26th, 2008
As part of our Scientific Support activities, ECDC is involved with catalyzing public health research. Our aim is to identify "directed" research needs (i.e. question- and need-based research goals) and to coordinate the application of results between key stakeholders. To achieve these goals, ECDC must keep abreast with state-of-the-art research ...
Posted in Respiratory / Asthma | No Comments »
Wednesday, February 20th, 2008
Inverseon, Inc. announces the publication of a rapid communication of groundbreaking research led by Professor Richard Bond of the University of Houston, Inverseon's Scientific Founder. In the March article by Nguyen, et. al., in the American Journal of Respiratory Cell and Molecular Biology 2008; 38: 256-262, entitled, "Chronic Exposure to ...
Posted in Respiratory / Asthma | No Comments »
Tuesday, February 12th, 2008
The Business Intelligence firm La Merie S.L. reported that during the year 2008 results of major phase II studies in asthma with two different interleukin-13 antagonistic antibodies are expected which will be decisive for the validation of a hot target. Interleukin-13 is regarded to have a central in the development ...
Posted in Respiratory / Asthma | No Comments »
Thursday, February 7th, 2008
The Mayor of London, Ken Livingstone, launched the London-wide Low Emission Zone, designed to reduce harmful emissions from the most polluting diesel-engined lorries, coaches and buses. Cars and motorcycles are not affected.
The capital has the worst air pollution in the UK and among the worst in Europe. Over one million ...
Posted in Respiratory / Asthma, Water - Air Quality | No Comments »
Thursday, November 1st, 2007
The Joint Commission has officially launched its COPD Disease-Specific Care Program. Based on standards developed with input from an expert task force that included AARC member Brian L. Smith, BA, RRT, the program will give health care organizations the chance to demonstrate their commitment to state-of-the-art practices in the management ...
Posted in Respiratory / Asthma | No Comments »
Thursday, November 1st, 2007
The American Lung Association offers a variety of resources for those affected by the wildfires still burning in Southern California. The following links contain useful information on breathing guidelines, air-filtering machines, and protective masks:
From the American Lung Association
- California Fires - Tips to Protect Your Lungs
Resources from the American Lung ...
Posted in Respiratory / Asthma | No Comments »
Thursday, November 1st, 2007
The examination of clinical, technical, managerial and financial components of healthcare delivery to the non hospital-bound asthmatic and COPD (Chronic Obstructive Pulmonary Disease) patient will be the topic of Stevens Institute of Technology's next healthcare roundtable, to be held today Wednesday, October 31, 2007, from 3-5 p.m. in Room 122 ...
Posted in Respiratory / Asthma | No Comments »
